CINI, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 2.185
EU - Europa 1.007
AS - Asia 584
AF - Africa 42
SA - Sud America 6
Totale 3.824
Nazione #
US - Stati Uniti d'America 2.181
GB - Regno Unito 375
CN - Cina 249
SG - Singapore 171
DE - Germania 149
SE - Svezia 110
IT - Italia 103
VN - Vietnam 76
IN - India 65
FR - Francia 50
IE - Irlanda 50
UA - Ucraina 50
RU - Federazione Russa 42
EE - Estonia 34
ZA - Sudafrica 34
BE - Belgio 14
FI - Finlandia 9
CH - Svizzera 7
JP - Giappone 6
CA - Canada 4
GR - Grecia 4
JO - Giordania 4
SC - Seychelles 4
HK - Hong Kong 3
RO - Romania 3
BR - Brasile 2
MY - Malesia 2
NL - Olanda 2
PE - Perù 2
SA - Arabia Saudita 2
TG - Togo 2
TR - Turchia 2
AR - Argentina 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
UZ - Uzbekistan 1
Totale 3.824
Città #
Fairfield 356
Southend 335
Santa Clara 181
Chandler 177
Woodbridge 158
Singapore 154
Ashburn 150
Houston 141
Cambridge 136
Wilmington 136
Seattle 125
Ann Arbor 103
Princeton 79
Nanjing 51
Dublin 50
Boardman 47
Dong Ket 44
Padova 37
Westminster 37
Berlin 25
Shenyang 24
Dearborn 22
Jacksonville 22
Jinan 21
Turin 21
Saint Petersburg 18
Hebei 16
San Diego 15
Brussels 14
Bologna 12
Changsha 10
Hangzhou 10
Beijing 9
Helsinki 9
Zhengzhou 9
Fuzhou 7
Haikou 7
Jiaxing 7
Lanzhou 7
Nanchang 7
Guangzhou 6
Los Angeles 6
Norwalk 6
Tianjin 6
Kunming 5
Milan 5
Redmond 5
Tokyo 5
Amman 4
Bern 4
Bremen 4
Falls Church 4
Mahé 4
Medford 4
Mülheim 4
Olalla 4
Ningbo 3
Paris 3
Shenzhen 3
Buffalo 2
Bühl 2
Costa Mesa 2
Frankfurt am Main 2
Harbin 2
Hefei 2
Kilburn 2
Kuala Lumpur 2
Las Vegas 2
Lausanne 2
Lima 2
Lomé 2
London 2
Maruggio 2
Orange 2
Qingdao 2
Redwood City 2
Riyadh 2
San Francisco 2
Soc Trang 2
Springfield 2
São Paulo 2
Taizhou 2
Toronto 2
Wenzhou 2
Wuhan 2
Xi'an 2
Abidjan 1
Amsterdam 1
Bari 1
Budapest 1
Busto Arsizio 1
Castelnuovo Rangone 1
Central District 1
Chengdu 1
Chiswick 1
Chongqing 1
Clearwater 1
Delhi 1
Ergolding 1
Esslingen am Neckar 1
Totale 2.942
Nome #
Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal. 156
A new rapid bedside assay for D-dimer measurement (Simplify D-dimer) in the diagnostic work-up for deep vein thrombosis. 153
Age and gender specific cut-off values to improve the performance of D: -dimer assays to predict the risk of venous thromboembolism recurrence. 141
Diagnostic Accuracy of a New d -Dimer Assay (Sclavo Auto d -Dimer) for Exclusion of Deep Vein Thrombosis in Symptomatic Outpatients 137
D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. 121
High plasma levels of factor VIII and risk of recurrence of venous thromboembolism 121
D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis. 118
D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis 117
G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease. 114
Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs 109
Evaluation of a chemiluminescent immunoassay, the HemosIL AcuStar D-Dimer, in outpatients with clinically suspected deep venous thrombosis 109
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study 109
Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia. 108
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin. 108
Oral contraceptive use in women with poor anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis. 106
D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome 105
Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels. 105
D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units 104
D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. 103
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms. 102
Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study). 102
Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study 99
A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms 95
Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies 95
Thrombin generation and intracranial atherosclerotic disease in patients with a transient ischaemic attack 95
Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. 94
Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels. 92
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis. 91
The influence of VKORC1 3730 G > A polymorphism on warfarin dose: reply. 86
Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil D-dimer HS 500, in patients with clinically suspected venous thromboembolism. 86
Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia 86
The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis 85
No early signs of atherosclerotic alterations in carriers of inherited thrombophilia. 84
Thrombophilic risk factors and peripheral arterial disease severity. 83
null 80
Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women. 73
The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients. 46
Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. 34
Thrombotic burden, D-dimer levels and complete compression ultrasound for diagnosis of acute symptomatic deep vein thrombosis of the lower limbs. 26
Incidence and clinical outcomes of heparin-induced thrombocytopenia: 11 year experience in a tertiary care university hospital 24
Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry 11
Totale 3.913
Categoria #
all - tutte 9.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.012 0 0 0 0 134 158 164 172 218 69 40 57
2020/2021443 116 51 18 19 9 15 14 19 51 27 16 88
2021/2022603 79 32 46 27 62 41 21 43 17 51 61 123
2022/2023649 106 108 26 97 42 49 14 37 84 20 47 19
2023/2024114 5 36 17 8 13 7 5 5 1 4 5 8
2024/2025511 19 152 54 40 246 0 0 0 0 0 0 0
Totale 3.913